Author: qreyes

A controlled substance is a drug or chemical whose manufacture, possession, and use are regulated by the government. The regulation takes into account factors such as medical use, potential for abuse, and safety or dependence liability. Under the Controlled Substances Act (CSA), substances are classified into five schedules based on these criteria. Controlled substances require…

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.8% on Friday. The Dow traded up 0.49% to 38,705.29 while the NASDAQ rose 1.81% to 15,639.81. The S&P 500 also rose, gaining, 1.20% to 4,965.03. Check This Out: Amazon To Rally Over 41%? Here Are 10 Top Analyst Forecasts…

Under the Inflation Reduction Act, Medicare is poised to send initial offers to manufacturers of the first ten drugs chosen for negotiation, challenging the established prices set by pharmaceutical companies.  This historic initiative aims to alleviate the financial burden on seniors, who, in 2022, spent an estimated $3.4 billion out-of-pocket for these crucial medications.  The program directly…

China’s gaming regulator, the National Press and Publication Administration (NPPA), unexpectedly approved a new batch of 32 foreign video games, easing concerns in the market after the recent scrapping of a controversial gaming regulation. Notable among the approvals is the hit title Dungeon & Fighter (DnF) Mobile, operated in China by Tencent Holdings ADR (OTC…

Corteva, Inc. (NYSE: CTVA) reported better-than-expected fourth-quarter financial earnings, after the closing bell on Wednesday. Corteva reported quarterly adjusted earnings of 15 cents per share, which beat the analyst estimates of 6 cents and representing a 6.25% decrease over earnings of 16 cents per share year-over-year. The company reported quarterly sales of $3.71 billion, representing…

MGIC Investment Corporation (NYSE: MTG) reported better-than-expected fourth-quarter earnings after the closing bell on Wednesday. MGIC Investment posted adjusted earnings of 67 cents per share, beating market estimates of 57 cents per share. The company’s quarterly sales came in at $283.96 million versus expectations of $292.72 million, according to data from Benzinga Pro. Tim Mattke,…